[中药调控的铁死亡通路及其干预]

[Ferroptosis pathway and its intervention regulated by Chinese materia medica].

作者信息

Xu Wen-Hui, Li Cang-Hai, Jiang Ting-Liang

机构信息

Research Center of Artemisinin, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Tang Center for Herbal Medicine Research, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(20):4019-4026. doi: 10.19540/j.cnki.cjcmm.20180517.001.

Abstract

Ferroptosis is a new form of regulated cell death which is different from apoptosis, necrosis and autophagy, and results from iron-dependent lipidperoxide accumulation. Now, it is found that ferroptosis is involved in multiple physiological and pathological processes, such as cancer, arteriosclerosis, neurodegenerative diseases, diabetes, antiviral immune response, acute renal failure, hepatic and heart ischemia/reperfusion injury. On the one hand, it could be found the appropriate drugs to promote ferroptosis to clear cancer cells and virus infected cells, etc. On the other hand, we could inhibit ferroptosis to protect healthy cells. China has a wealth of traditional Chinese medicine resources. Chinese medicine contains a variety of active ingredients that regulate ferroptosis. Here, this paper reported the research of ferroptosis pathway, targets of its inducers and inhibitors that have been discovered, and the regulatory effects of the discovered Chinese herbs and its active ingredients on ferroptosis to help clinical and scientific research.

摘要

铁死亡是一种新的程序性细胞死亡形式,不同于凋亡、坏死和自噬,它是由铁依赖性脂质过氧化物积累引起的。目前发现,铁死亡参与多种生理和病理过程,如癌症、动脉硬化、神经退行性疾病、糖尿病、抗病毒免疫反应、急性肾衰竭、肝脏和心脏缺血/再灌注损伤等。一方面,可以寻找合适的药物来促进铁死亡,以清除癌细胞和病毒感染细胞等。另一方面,可以抑制铁死亡来保护健康细胞。中国拥有丰富的中药资源。中药含有多种调节铁死亡的活性成分。在此,本文报道了铁死亡途径、已发现的其诱导剂和抑制剂的靶点,以及已发现的中药及其活性成分对铁死亡的调节作用,以助力临床和科研。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索